Alyeska Investment Group
COYA icon

Alyeska Investment Group’s Coya Therapeutics COYA Stock Holding History

Alyeska Investment Group’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Hold
800,000
– – 0.01% 509
2026
Q1 		$3.15M Hold
800,000
– – 0.01% 522
2025
Q4 		$4.64M Buy
+800,000
New +$4.86M 0.01% 469

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Alyeska Investment Group's COYA Position: Q2 2026 in Review

Alyeska Investment Group held its Coya Therapeutics (COYA) position steady in Q2 2026 at 800,000 shares worth $4.68M. The position accounts for 0.01% of the portfolio, ranked #509.

Alyeska Investment Group first reported a position in COYA in Q4 2025 and has held it in 3 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Alyeska Investment Group held 800,000 shares of Coya Therapeutics worth $4.68M as of Q2 2026.
  • Alyeska Investment Group left its Coya Therapeutics share count unchanged in Q2 2026.
  • Coya Therapeutics made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #509 holding.
  • Alyeska Investment Group first reported a position in Coya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.